Selected Drugs Clear All
MultiCheck Results
- 8
Interactions
Avoid/Use Alternative |
||
|
Excedrin Migraine
(acetaminophen/ aspirin/ caffeine) + Theraflu Daytime Severe Cold Relief
(acetaminophen/ dextromethorphan) |
||
|
Theraflu Daytime Severe Cold Relief
(acetaminophen/ dextromethorphan) + Uribel
(methenamine/ sodium phosphate/ phenyl salicylate/ methylene blue/ hyoscyamine) |
||
Avoid/Use Alternativedextromethorphan + methylene blue oral use alternative or monitor serotonin syndrome sx w/in 14 days of methylene blue use, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase) Caution Advisedacetaminophen + hyoscyamine caution advised w/ oral acetaminophen: combo may decr. peak acetaminophen levels, delay analgesic onset, efficacy (absorption delayed, possibly decreased) |
||
Monitor/Modify Tx |
||
|
Excedrin Migraine
(acetaminophen/ aspirin/ caffeine) + Uribel
(methenamine/ sodium phosphate/ phenyl salicylate/ methylene blue/ hyoscyamine) |
||
Monitor/Modify Txcaffeine + hyoscyamine monitor HR; avoid excessive caffeine intake: combo may incr. risk of tachycardia (additive effects) Caution Advisedacetaminophen + hyoscyamine caution advised w/ oral acetaminophen: combo may decr. peak acetaminophen levels, delay analgesic onset, efficacy (absorption delayed, possibly decreased) aspirin + phenyl salicylate caution advised: combo may incr. salicylate levels, risk of adverse effects (additive effects, duplicate therapy) |
||
Caution Advised |
||
|
Excedrin Migraine
(acetaminophen/ aspirin/ caffeine) + Vyleesi
(bremelanotide) |
||
|
Theraflu Daytime Severe Cold Relief
(acetaminophen/ dextromethorphan) + Vyleesi
(bremelanotide) |
||
Additional Considerations |
||
|
dextromethorphan
in Theraflu Daytime Severe Cold Relief
|
||
|
add MAO inhibitor to Interaction Check if recent (14 days) use |
||
|
bremelanotide
in Vyleesi
|
||
|
avoid combo with oral drugs requiring quick onset and/or efficacy dependent on threshold concentrations; bremelanotide delays gastric emptying, may reduce rate and extent of oral drug absorption |
||
|
hyoscyamine
in Uribel
|
||
|
caution advised with concurrent oral drugs requiring rapid onset; hyoscyamine delays gastric emptying, may alter absorption of concomitant oral drugs |
||